(NP (NP (JJ Single) (NN point) (NN estimation)) (PP (IN of) (NP (NP (NN glucocorticoid) (NNS receptors)) (PP (IN in) (NP (NP (NNS lymphocytes)) (PP-COOD (PP (IN of) (NP (JJ normal) (NNS subjects))) (CC and) (PP (IN of) (NP (NP (NNS children)) (PP (IN under) (NP (JJ long) (NN term) (NN glucocorticoid) (NN treatment)))))))))) (. .))
(S (NP-SBJ-45 (NP (DT A) (JJ single) (NN point) (NN assay)) (PP (IN of) (NP (NP (NP (NN glucocorticoid) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NN GR)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ human) (NNS lymphocytes))))) (PP (VBN based) (PP (IN on) (NP (NP (DT the) (NN measurement)) (PP (IN of) (NP (JJ specific) (NN dexamethasone) (NN binding))))))) (VP (VBZ has) (VP (VBN been) (VP-COOD (VP (VBN developed) (NP (-NONE- *-45))) (CC and) (VP (VBN compared) (NP (-NONE- *-45)) (PP (IN with) (NP (DT a) (JJ common) (JJ multi-point) (NN Scatchard) (NN analysis))))))) (. .))
(S (NP-SBJ-47 (NP (DT The) (NN assay) (NN conditions)) (: -) (NP-COOD (NP (NP (NN concentration) (PP (IN of) (NP (DT the) (NN ligand)))) (NP (CD 20) (NN (l nmol)))) (, ,) (NP (NN incubation) (NN time) (CD 2) (NN h)) (CC and) (NP (NP (DT the) (NN cell) (NN count) (QP (CD 2-6)) (CD mil.) (NNS (tube cells))) (PP (IN in) (NP (DT the) (NN assay) (NN volume) (CD 0.25) (NN ml)))))) (VP (VBD were) (VP (VBN found) (S (NP-SBJ (-NONE- *-47)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ optimal))))))) (. .))
(S (NP-SBJ-46 (DT An) (NN attempt) (S (-NONE- *ICH*-48))) (VP (VBD was) (ADVP (RB also)) (VP (VBN undertaken) (NP (-NONE- *-46)) (S-48 (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB use) (NP (DT a) (NN cell) (NN harvester)) (PP (IN for) (NP (NP (DT the) (NN separation)) (PP (IN of) (NP (NNS cells))) (PP (IN from) (NP (JJ unbound) (NN ligand)))))))))) (. .))
(S (SBAR-ADV (IN Though) (S (NP-SBJ-COOD (NP (NP (ADJP (RB specifically) (VBN bound)) (NN dexamethasone)) (VP (VBN measured) (NP (-NONE- *)) (PP (IN by) (NP (JJ whole-cell) (NN assay))))) (CC and) (NP (NP (DT that)) (VP (VBG using) (NP (NN cell) (NN harvester))))) (VP (VBD correlated) (ADVP (RB well))))) (, ,) (NP-SBJ (NP (ADJP (PP (RB almost) (IN by) (NP (CD one) (NN order))) (JJR lower)) (NNS values)) (VP (VBN obtained) (NP (-NONE- *)) (PP (IN with) (NP (DT the) (JJ latter) (NN method))))) (VP (VBP render) (S (NP-SBJ (PRP it)) (ADJP-PRD (JJ non-applicable) (PP (IN for) (NP (NN receptor) (NN quantitation)))))) (. .))
(S (NP-SBJ (NP (NP (DT The) (NNS results)) (PP (IN from) (NP (CD 9) (JJ healthy) (NNS volunteers)))) (PRN (-LRB- -LRB-) (FRAG (NP (JJ average) (NN GR) (NN concentration) (NP (QP (CD 7131) (CC (- +)) (CD 1256)) (NNS (cell sites))))) (-RRB- -RRB-))) (VP (VBD correlated) (ADVP (RB excellently)) (PP (IN with) (NP (NP (DT those)) (VP (VBN obtained) (NP (-NONE- *)) (PP (IN by) (NP (DT the) (NN Scatchard) (NN analysis))))))) (. .))
(S (NP-SBJ-49 (DT The) (JJ single) (NN point) (NN assay)) (VP (VBZ has) (VP (VBN been) (ADVP (RB also)) (VP (VBN applied) (NP (-NONE- *-49)) (PP (IN for) (NP (NP (NN determination)) (PP (IN of) (NP (NP (NN GH)) (PP (IN in) (NP (NP (CD 10) (NNS children)) (VP (VBN treated) (NP (-NONE- *)) (PP (IN with) (NP (NP (JJ large) (NNS doses)) (PP (IN of) (NP (NN prednisone))))))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ average) (NNS values)) (PP (IN from) (NP (JJ healthy) (NNS volunteers)))) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN from) (NP (NP (DT those)) (VP (VBN found) (NP (-NONE- *)) (PP (IN in) (NP (DT these) (NNS children)))))) (, ,) (SBAR (RB though) (S (NP-SBJ-50 (ADJP (RB much) (JJR broader)) (NN range)) (VP (VBD was) (VP (VBN found) (NP (-NONE- *-50)) (PP (IN in) (NP (NNS patients))))))))) (. .))
